Upon analyzing the expression of 11 model genes in prostate PRAD, we observed significant differential expression of eight genes (MYADM, MPDZ, LTBP2, DENND4C, PROK1, DDIT4, IGFBP3, and CFD) between normal and tumor tissues (Fig. 10A). This evidence concerns the gene LTBP2 and prostate adenocarcinoma.